{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:42:09Z","timestamp":1770903729009,"version":"3.50.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Cardiac magnetic resonance imaging (MRI) is an essential tool for the study of hypertrophic cardiomyopathies (HCM) and for differentiating HCM from conditions with increased ventricular wall thickness, such as cardiac storage diseases. Although cardiac MRI is already used for the diagnosis and characterization of some forms of storage diseases involving the myocardium, it has not yet been used to study myocardial involvement in neuronal ceroid lipofuscinosis (NCL). Here, we describe comprehensive cardiac MRI findings in a patient with the CLN3 form of NCL showing basal inferior interventricular septal hypertrophy with maintained indexed LV mass within reference values and low T1-native values. MRI findings support a finding of abnormal storage material within the myocardium in CLN3 disease. We recommend the possible routine use of cardiac MRI for early diagnosis of cardiac involvement in CLN3 disease (also termed juvenile NCL) and to monitor the effects of emerging CLN3 therapies on the myocardium as well.<\/jats:p>","DOI":"10.3389\/fneur.2022.942667","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T06:42:28Z","timestamp":1661150548000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiac magnetic resonance findings in neuronal ceroid lipofuscinosis: A case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Giancarlo","family":"Todiere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Della Vecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Aurora","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Barison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Ricca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Tessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Colombi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo Maria","family":"Santorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the european society of cardiology (ESC)","volume":"35","author":"Authors\/Task Force","year":"2014","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","article-title":"The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction","volume":"343","author":"Kim","year":"2000","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement","volume":"15","author":"Moon","year":"2013","journal-title":"J Cardiovasc Magn Reson."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/CMC.S19005","article-title":"Native T1 mapping of the heart-a pictorial review","volume":"8","author":"Germain","year":"2014","journal-title":"Clin Med Insights Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1148\/radiol.2018172613","article-title":"Use of Myocardial T1 Mapping at 30 T to differentiate Anderson-Fabry disease from hypertrophic cardiomyopathy","volume":"288","author":"Karur","year":"2018","journal-title":"Radiology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ijcard.2014.09.001","article-title":"Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance","volume":"177","author":"Smid","year":"2014","journal-title":"Int J Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim Biophys Acta."},{"key":"B9","doi-asserted-by":"publisher","first-page":"165643","DOI":"10.1016\/j.bbadis.2019.165643","article-title":"Cardiac pathology in neuronal ceroid lipofuscinoses (NCL): More than a mere co-morbidity","volume":"1866","author":"Rietdorf","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1600-0447.1979.tb00244.x","article-title":"A clinical study of 44 patients with juvenile amaurotic family idiocy","volume":"59","author":"S\u00f8rensen","year":"1979","journal-title":"Acta Psychiatr Scand."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1212\/WNL.0b013e31821435bd","article-title":"Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"76","author":"Ostergaard","year":"2011","journal-title":"Neurology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1699-0463.1981.tb00233.x","article-title":"Cardiac involvement in juvenile amaurotic idiocy\u2013a specific heart muscle disorder. Histological findings in 13 autopsied patients","volume":"89","author":"Reske-Nielsen","year":"1981","journal-title":"Acta Pathol Microbiol Scand A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1053\/ejpn.2000.0465","article-title":"Cardiac pathology in neuronal ceroid lipofuscinoses\u2013a clinicopathologic correlation in three patients","volume":"5","author":"Hofman","year":"2001","journal-title":"Eur J Paediatr Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000115699","article-title":"Cardiac involvement in juvenile ceroid lipofuscinosis of the Spielmeyer-Vogt-Sj\u00f6gren type: prospective noninvasive findings in two siblings","volume":"23","author":"Michielsen","year":"1984","journal-title":"Eur Neurol."},{"key":"B15","first-page":"15","article-title":"Review: Metabolic cardiomyopathy and conduction system defects in children","volume":"34","author":"Gilbert-Barness","year":"2004","journal-title":"Ann Clin Lab Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/jmri.27639","article-title":"Myocardial T1 Values at 1.5 T: Normal Values for General Electric Scanners and Sex-Related Differences","volume":"54","author":"Meloni","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1002\/mgg3.859","article-title":"The CLN3 gene and protein: what we know","volume":"7","author":"Mirza","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"754045","DOI":"10.3389\/fneur.2021.754045","article-title":"The genetic basis of phenotypic heterogeneity in the neuronal ceroid lipofuscinoses","volume":"12","author":"Gardner","year":"2021","journal-title":"Front Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/humu.21624","article-title":"Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses","volume":"33","author":"Kousi","year":"2012","journal-title":"Hum Mutat"},{"key":"B20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1469-8749.2010.03628.x","article-title":"Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"52","author":"Adams","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41419-018-0749-9","article-title":"Mechanism of neuroprotection by trehalose: controversy surrounding autophagy induction","volume":"9","author":"Lee","year":"2018"},{"key":"B22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/15548627.2018.1535292","article-title":"Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration","volume":"15","author":"Rusmini","year":"2019","journal-title":"Autophagy"},{"key":"B23","doi-asserted-by":"publisher","first-page":"812728","DOI":"10.3389\/fcell.2022.812728","article-title":"Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease)","volume":"10","author":"Kim","year":"2022","journal-title":"Front Cell Dev Biol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.942667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T06:42:32Z","timestamp":1661150552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.942667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":23,"alternative-id":["10.3389\/fneur.2022.942667"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.942667","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"article-number":"942667"}}